Carlet J
Service de Réanimation Polyvalente, Hôpital Saint-Joseph, Paris, France.
Pathol Biol (Paris). 1998 Apr;46(4):213-6.
The overall level of resistance to antimicrobials is high in Europe, most notably in intensive care units. Variations exist across countries, with the levels being highest in southern Europe. Staphylococcus aureus remains the most hazardous pathogen. Glycopeptide-resistant enterococci are relatively infrequent in Europe for the time being. Differences in measures used to control antimicrobial use and to prevent cross-contamination probably explain country-to-country differences in resistance levels. Substantial efforts are needed in both these areas in many countries, including France.
欧洲对抗菌药物的总体耐药水平较高,在重症监护病房尤为明显。各国存在差异,耐药水平在南欧最高。金黄色葡萄球菌仍然是最具危害性的病原体。耐糖肽肠球菌目前在欧洲相对较少见。用于控制抗菌药物使用和预防交叉污染的措施差异可能解释了各国耐药水平的不同。包括法国在内的许多国家在这两个领域都需要做出巨大努力。